Proactive Outreach With FIT
Part of paid clinical trials in Brooklyn, New York.
- Sponsor
- NYU Langone Health
- Study ID
- NCT06269744
- Status
- Enrolling By Invitation
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 45 Years - 75 Years
- Healthy Volunteers
- Accepted
Interventions
- Proactive Screening Outreach — BEHAVIORALIndividuals in the interventional arm will receive an information letter, followed by mailed FIT kit. Individuals that do not respond will receive reminder phone calls. Individuals that do respond will receive navigation to assist with completion of FIT and the colonoscopy if FIT is abnormal. Clinic processes will be closely followed and the primary care provider will be informed of the program.
Study Details
The purpose of the study is to boost colorectal cancer (CRC) screening rates in an underserved population in Brooklyn through organized, proactive outreach of mailed Fecal Immunochemical Tests (FIT), utilizing evidence-based interventions tailored to the needs of the population.
Key Dates
- Start date
- Mar 13, 2024
- Status verified
- Dec 2025
- Primary completion
- Dec 15, 2025
- Completion
- Apr 30, 2026
Study Design
- Enrollment
- 3,000 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: Proactive Screening OutreachParticipants assigned to the interventional arm will receive proactive outreach of mailed Fecal Immunochemical Tests (FIT) to screen for colorectal cancer.
- No Intervention: Standard of CareParticipants assigned to the standard of care group will receive usual care (i.e., opportunistic screening for colorectal cancer).
Primary Outcome Measure
Proportion of Participants who Complete FIT Test by Month 6 [ Time Frame: Up to Month 6 ]
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Community Health Care Network of New York | Brooklyn | New York | 11206 | - |
| NYU Langone Health | Brooklyn | New York | 11203 | - |
Find similar trials in Brooklyn, NY
By condition
By specialty
Related Studies
- A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsPHASE1/PHASE2 · Recruiting · Merus B.V. · La Jolla, California
- Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC FusionsPHASE1/PHASE2 · Recruiting · IDEAYA Biosciences · Los Angeles, California
- Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal MetastasesPHASE1/PHASE2 · Recruiting · Roswell Park Cancer Institute · Buffalo, New York
- Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid TumorsPHASE1 · Recruiting · Bicara Therapeutics · La Jolla, California